Dual-specificity phosphatase 10 alleviates severe acute pancreatitis via the dephosphorylation of TAK1 Authors: Chaopeng Mei, Guanghui Li, Meng Wang, Huning Cui, Qianqian He, Mengwei Cui, Qiaofang Wang, Yanna Liu, Dejian Li, Yaodong Song, Jiye Li, Sanyang Chen, Changju Zhu Published: 2026 ABSTRACT Severe acute pancreatitis (SAP) is a serious condition characterized by an intense systemic inflammatory response that can lead to persistent multiple organ failure and sepsis. Dual-specificity phosphatase 10 (DUSP10), has been implicated in immunity and inflammation; however, its involvement in SAP remains unclear. This study focuses on exploring the function and mechanism of DUSP10 in SAP. As a classical experimental model of SAP, L-arginine was used for in vitro and in vivo studies. A DUSP10 global knockout (KO) mice model and administration of adeno-associated virus with DUSP10 were used to further investigate the function of DUSP10 in SAP. Disulfiram and 5Z-7-ox, inhibitors of pyroptosis and TAK1, were applied to study the protective mechanism of DUSP10. We found downregulated expression of DUSP10 in in vitro and in vivo SAP models. Pancreatic damage was largely enhanced in DUSP10−/− mice and AR42J cells treated with shDUSP10, but was attenuated in mice and AR42J cells overexpressing DUSP10; the related lung and kidney damage, inflammatory response and oxidative stress paralleled these results. DUSP10 deficiency exacerbates pyroptosis during SAP, and inhibition of pyroptosis by DSF treatment protects against DUSP10 deficiency in aggravating SAP. Immunofluorescence and immunoprecipitation assays prove direct physical binding of DUSP10 to TAK1, and treatment with 5Z-7-ox reduced SAP severity in DUSP10−/− mice, showing that DUSP10 affected the dephosphorylation of the TAK1, and regulated the degree of pyroptosis by mediating the TAK1/JNK/p38 pathway. In conclusion, our study indicates that DUSP10 is a novel mediator of SAP and can inhibit pyroptosis via the dephosphorylation of TAK1.Graphical Abstract Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1007/s00018-026-06278-y. Introduction Acute pancreatitis (AP) is a common inflammatory disease of the gastrointestinal tract with varying severity levels. Most cases tend to have mild symptoms and heal spontaneously. However, approximately 25% of patients can develop into severe AP (SAP) with a high risk of mortality that is frequently associated with pancreatic necrosis and persistent organ failure [1, 2]. The pathogenesis of SAP remains incompletely clarified and clinical treatment interventions remain limited to traditional medical support and surgery [3]. Therefore, further exploring its molecular mechanisms and finding new therapeutic targets are of great significance. Systemic inflammation plays a key role in the pathogenesis of SAP. This disease process usually begins with the premature activation of inflammatory pathways within acinar cells, triggering localized tissue damage and inflammation. When this initial response spirals out of control, a cascade of inflammatory mediators floods the bloodstream, setting off a chain reaction that culminates in systemic inflammatory response syndrome (SIRS) and multi-organ failure (MODS) [4, 5]. Oxidative stress, as a crucial role in SAP, significantly contributes to cellular damage [6]. In the pancreas, damage to acinar cells and activation of immune cells lead to a rapid increase in free radicals, which are compounded by elevated levels of malondialdehyde (MDA) and lower levels of superoxide dismutase (SOD) and total glutathione (GSH) [7]. Hydrogen peroxide (H2O2), acting as a secondary messenger from NADPH oxidase, is a prime producer of reactive oxygen species (ROS) during the inflammatory response [8]. Excessive production of ROS results in tissue death, zymogen granule disintegration, granulocyte migration, and a surge in amylase and lipase activity—all exacerbating inflammation and pancreatitis [9–11]. Pyroptosis is a type of programmed cell death, and marked by the spillage of cellular material and pro-inflammatory cytokines [12, 13]. Recent studies indicate a connection between pyroptosis and the pathophysiology of pancreatic parenchymal cell death [14–16]. Therefore, SAP can be significantly modulated by suppressing inflammatory response, oxidative stress, and pyroptosis. The initiation of the mitogen-activated protein kinase (MAPK) pathway plays a key role in the progression of pancreatic injury. Inhibition of the MAPK pathway can significantly reduce the inflammation, oxidative stress, and pyroptosis associated with AP [17–21]. Therefore, there is a critical need to identify novel approaches to control MAPK signaling for the treatment of AP. Dual-specificity phosphatase 10 (DUSP10) belongs to the mitogen-activated protein kinase phosphatases (MKP) family and functions by the dephosphorylation of specific serine/threonine and tyrosine sites on the target kinase, negatively regulating MAPK signaling and has been implicated in various diseases [22–24]. Previous studies have shown that DUSP10 deletion amplifies MAPK pathway activation in LPS-triggered acute lung injury, resulting in a heightened inflammatory response and more severe pulmonary injury [25]. Several naturally occurring anti-inflammatory agents have been identified that can increase the expression of DUSP10, which regulates inflammatory mediators via MAPKs [26, 27]. Such as Andrographolide can suppresses HIF-1α and ET-1 expression under hypoxia via the HO-1/CO/cGMP/DUSP10 axis in EA [28]. JNK/p38, a component of the MAPK pathway, can be regulated by MKP-5 to reduce the dysfunction and apoptosis induced by lipotoxicity and glucolipotoxicity [29, 30]. Nevertheless, the exact role of DUSP10 in SAP has yet to be clarified. Our research aims to explore the influence of DUSP10 in SAP and assess its potential protective effects against SAP and SAP-induced lung and kidney injury while determining its ability to mitigate pyroptosis. In this exploratory research, DUSP10 levels were notably downregulated in the pancreas of wild-type (WT) SAP mice and L-arginine (L-Arg)-treated pancreatic acinar cells, suggesting a potential involvement of DUSP10 in SAP. To confirm the participation of DUSP10 in SAP and to elucidate the underlying processes, we used DUSP10 knockout (DUSP10−/−) and AAV-DUSP10 mice to construct a model of SAP. Our studies in vivo and in vitro showed that DUSP10 regulated the inflammation, oxidative stress, and pyroptosis during SAP, and the inhibition of pyroptosis protected against DUSP10 deficiency in aggravating SAP. In addition, we found the upregulated pyroptosis process during SAP was demonstrated to be regulated by dephosphorylation of TAK1.Taken together, these findings strongly suggest that DUSP10 plays a vital role in the development of AP. Materials and methods Animals Male C57BL/6J mice 6 to 8 weeks old and weighing between 18 and 22 g were obtained from the Experimental Animal Center of Zhengzhou University. DUSP10 knockout (DUSP10−/−) mice with the same genetic background were provided by Professor Liang Yinming of Xinxiang Medical College. All experimental subjects were housed in a unified laboratory environment with a 12-hour light and 12-hour dark schedule and unlimited access to regular feed and sterile drinking water. To investigate the effects of DUSP10 overexpression in the pancreas, the mice received intraperitoneal injections of an adeno-associated virus (AAV) serotype 2/8 carrying either the DUSP10 gene (AAV-DUSP10) or a GFP control vector (AAV-GFP). After three weeks, the SAP model was established. A total of 96 mice were involved, with six animals in each experimental group. SAP Model and treatment We established the mouse model of SAP as previously outlined [31]. Mice were fasted for 12 h and had free drinking water. The L-Arg solution was prepared by dissolving L-Arg in sterile physiological saline and adjusting the pH to 7.0 with 10% HCl. Mice were injected intraperitoneally with L-Arg at 4 g/kg body weight twice at an interval of 1 h. The control group was injected intraperitoneally with an equal volume of physiological saline. For histological studies, sections comprising one-third of the pancreas, lungs and kidneys were collected and fixed in 10% neutral buffered formalin. The remaining tissues were quickly frozen in liquid nitrogen and stored at-80 °C for subsequent analysis. Blood samples were collected by orbital puncture and then centrifuged at 4 °C with a centrifugal force of 3000×g for 10 min to separate the serum and store at-80 ° C until needed. DUSP10−/− and WT mice were injected with disulfiram (DSF) at 50 mg/kg, i.p., a pyroptosis inhibitor [31], 24 h and 3 h before L-Arg injection according to the previously described technique to investigate the effect of DSF on SAP therapy [12, 32, 33]. To explore the roles of TAK1 and DUSP10 on SAP, the TAK1-specific inhibitor 5Z-7-oxozeaenol (5 mg/kg) was administered intraperitoneally 30 min prior to L-Arg injection, as previously documented [34–36]. Dataset analysis from the GEO database In accordance with established protocols [37], the GSE194331 dataset, comprising 10 SAP samples and 32 normal samples, was obtained from the National Center for Biotechnology Information (NCBI)’s Gene Expression Omnibus (GEO) database. The gene expression differences between the two groups, specifically focusing on DUSP10 expression, were analyzed using SPSS. Measurement of serum amylase and lipase levels Serum amylase levels and lipase activity were assessed using test kits, and all operations strictly followed the instructions provided by each manufacturer. Assessment of oxidative stress and inflammatory factors To evaluate reactive oxygen species (ROS) production, AR42J cells were exposed to L-Arg at a concentration of 5 mg/mL for 24 h. The cells were then stained with 10 µM 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) diluted 1:1000 in serum-free medium. After incubation at 37 °C for 20 min, the cells were washed three times with serum-free medium and then observed under a fluorescence microscope. Mouse pancreas samples were weighed and homogenized in ice-cold physiological saline (0.9%) at a ratio of 1:9 (w/v) to prepare a 10% suspension. The homogenate was centrifuged at 4 °C with a centrifugal force of 8000×g for 10 min, which was then analyzed for GSH, MDA, SOD, and H2O2 levels. Total protein concentration was quantified using the BCA assay kit following the manufacturer’s protocol. Additionally, serum samples were assessed for inflammatory cytokines, including IL-6, TNF-α, MCP-1, IL-1β, and IL-18, via ELISA following the guidelines provided in the commercial detection kit. Assessment of LDH release Cells were initially seeded into 6-well plates and placed under the specified experimental conditions. Following treatment, the culture medium was harvested and spun down at 400×g for 5 min to remove any cell debris. The clarified supernatants were then transferred to a 96-well plate in triplicate and analyzed using the LDH Cytotoxicity Detection Kit. Hematoxylin and eosin (HE) staining and immunohistochemistry (IHC) Tissue samples from the pancreas, lungs and kidneys were embedded in paraffin, cut into 4 μm sections, and processed according to the manufacturer’s instructions. HE staining was performed to observe tissue structure and pathology. Pathological grading of pancreatic tissue was performed according to Schmidt’s scoring criteria [37, 38], with a score of 0–4. For immunohistochemical procedures, tissue sections are first dewaxed in xylene and then gradually hydrated in an ethanol bath. Antigen retrieval was carried out using a specific buffer, followed by blocking endogenous peroxidase with 3% hydrogen peroxide. To prevent binding of non-specific antibodies, sections were pre-incubated with 10% goat serum. Primary antibodies against CD11b, MPO, LY6G and 4-HNE were added and incubated overnight at 4 °C. After rinsing with PBS, secondary antibodies were added and incubated at room temperature for 30 min. Chromogenic testing was performed using DAB substrate and slides were counterstained with hematoxylin. The stained sections were then sealed with neutral gum and photographed and imaged under a microscope. Primary pancreatic cell isolation Primary pancreatic acinar cells, CD45 + immune cells, and pancreatic ductal cells were isolated from control and SAP mice. Briefly, pancreatic tissues were rapidly collected, minced into small fragments, and digested with collagenase-containing buffer at 37 °C. The digested tissues were filtered through a cell strainer and centrifuged to obtain different cellular fractions. Acinar cell-enriched fractions were collected based on their morphology and sedimentation characteristics. CD45 + immune cells were enriched using CD45-based magnetic separation. Ductal cell-enriched fractions were collected and further validated by ductal cell marker expression. The purity of each cell fraction was verified by RT-qPCR using amylase, CD45, and CK19 as markers for acinar cells, immune cells, and ductal cells, respectively. Cell culture and treatment AR42J cells were grown in DMEM medium and supplemented with 10% fetal bovine serum. The cultures were preserved at 37 °C under a 5% CO₂-enriched atmosphere. When the cells reached approximately 80–90% confluence, they were exposed to 5 mg/mL of L-Arg for a 24-hour period prior to harvesting samples for subsequent analyses. Plasmid construction and cell transfection Plasmids for overexpressing proteins (Flag and Flag-DUSP10) and shRNA for gene silencing (GFP negative control and sh-DUSP10) were obtained from PPL Company. To produce lentiviral particles, HEK-293 cells were transfected with lentiviral vectors alongside packaging plasmids (CMV and VSVG) by Lipo3000. After 48 h, viral particles were harvested from the medium and used to transfect AR42J cells. Cells with stable expression were obtained after 7 days of screening in a medium containing 2 µg/mL puromycin. Cell injury assay Cellular injury was assessed through CCK-8 cell viability assay and DAPI/PI nuclear staining. For the CCK-8 assay, AR42J cells were seeded at 8,000 cells/well in 96-well plates, ensuring they reached about 80% confluence before proceeding. 10 µL of the CCK-8 reagent was added to each well post-treatment following the manufacturer’s guidelines. After incubation for one hour at 37 °C, the plates were then analyzed using a microplate reader to measure absorbance at a wavelength of 450 nm. The level of cellular viability was inferred from these absorbance readings. After treatment, the cells were stained with DAPI/PI to visualize their nuclei, and their overall health was examined under a fluorescence microscope. Immunofluorescence For immunofluorescence staining, cells cultured on coverslips were first fixed with 4% polyformaldehyde solution, then permeabilized with 0.1% Triton X-100, blocked with goat serum, and the samples were incubated with the appropriate primary antibody at 4 °C overnight. Subsequently, fluorescently tagged secondary antibodies were applied for one hour. For nuclear visualization, DAPI was used as a counterstain for 10 min before fluorescence microscopy imaging. Immunoprecipitation For co-immunoprecipitation experiments, AR42J cells were transfected with Flag-DUSP10 plasmids. Cells were lysed in ice-cold NP-40-based lysis buffer supplemented with protease and phosphatase inhibitors to preserve protein-protein interactions. After centrifugation at 13,000 × g for 10 min at 4 °C, the supernatants were incubated with anti-Flag magnetic beads overnight at 4 °C. Normal IgG was used as a negative control. After washing three times with lysis buffer, the immunoprecipitated complexes were eluted with SDS-PAGE loading buffer and analyzed by Western blotting using antibodies against TAK1 and Flag/DUSP10. Real-time quantitative polymerase chain reaction (RT-qPCR) Utilizing the TRIzol reagent, we extracted the total RNA. Subsequently, we synthesized the cDNA and performed the amplification step. We used the 2^-ΔΔCt technique to assess mRNA expression and normalized based on GAPDH expression. The specific primer sequences used are provided in Supplementary Table 1. Protein extraction and Western blotting Proteins were extracted from pancreatic tissue and AR42J cells using RIPA buffer added with protease and phosphatase inhibitors. The concentration was evaluated with the BCA detection kit, and an equal amount of protein samples were separated on a 10% SDS-PAGE gel, then transferred to a PVDF membrane, blocked the membrane for 20 min at room temperature, followed by three washes with TBST buffer for 10 min each time. For protein detection, the membrane was incubated overnight on an orbital shaker at 4 °C with primary antibodies against targets such as p-P65 (1:1000), P65 (1:1000), GAPDH (1:3000), NLRP3 (1:1000), ASC (1:500), Caspase 1 (1:1000), GSDMD (1:1000), GSDMD-N (1:1000), IL-1β (1:500), p38 (1:1000), p-p38 (1:500), JNK (1:1000), p-JNK (1:500), TAK1 (1:1000), p-TAK1 (1:500), HO-1 (1:1000), and NQO-1 (1:1000). Each primary antibody was used at the designated dilution and washed three times with TBST. After 10 min each time, the membrane was incubated with HRP-labeled secondary antibody (anti-rabbit or anti-mouse IgG, dilution ratio of 1:5000) for one hour at room temperature. The protein bands were developed using the ECL chemiluminescent detection reagent and imaged using LI-COR’s Odyssey system. The bands were subjected to optical density analysis using ImageJ software and normalized using GAPDH as a loading control. The data were from at least three independent biological experiments. Protein concentration, and Cell counting in bronchoalveolar lavage fluid (BALF) The process started with lavaging the left lung using 0.5 ml of cold PBS introduced via tracheal intubation, then withdrawing the fluid after a 10-second pause. This lavage was performed three times to ensure thorough sampling, yielding recovery rates above 85%. The collected samples were centrifuged at 2000 rpm for 10 min at 4 °C. The resulting supernatant, free of cells, was used to measure protein concentration with a BCA assay kit. Meanwhile, the cell pellets were gently resuspended, and cell counts were performed using a hemocytometer from Sigma-Aldrich, St. Louis. Statistical analysis The dataset was analyzed using IBM SPSS Statistics (Version 21.0, Armonk, NY), with outcomes reported as means accompanied by standard deviations. For pairwise group comparisons, independent two-sample t-tests (two-tailed) were applied, whereas one-way analysis of variance (ANOVA) was utilized when examining differences across three or more groups. Statistical significance levels are classified as follows: *p < 0.05, **p < 0.01, and ***p < 0.001. Results DUSP10 Expression is downregulated after SAP DUSP10 expression was significantly downregulated following SAP based on transcriptomic data obtained using blood samples from 32 healthy people and 10 SAP patients from the GEO database (GSE194331) of NCBI (Fig. 1A and B). Then, we examined the expression of DUSP10 in pancreatic tissues and AR42J cells following SAP to analyze the function of DUSP10 in SAP. The serum amylase levels and lipase activity of SAP mice were higher than in the sham group (Fig. 1C); these markers are regarded to be the most sensitive and specific indicators of pancreatic acinar cell injury. In addition, HE staining showed the severity of pancreatic tissue edema, inflammatory cells infiltration, and necrosis was significantly increased in the SAP group (Fig. 1D), and the expression of DUSP in pancreatic tissue was considerably downregulated (Fig. 1E, F and G). In vitro tests provided additional confirmation of these findings. Compared to the control group, L-Arg significantly decreased the viability of rat pancreatic acinar AR42J cells (Fig. S1A), as well as the expression level of DUSP10 in AR42J (Fig. 1F and H). In parallel, we generated additional caerulein-induced mild acute pancreatitis and caerulein + LPS–induced SAP models. Consistent with the L-arginine model, DUSP10 protein and mRNA levels were markedly decreased in pancreatic tissues from both models (Fig. S6A and B). To determine the pancreatic cellular source of DUSP10, we isolated primary pancreatic acinar cells, CD45 + immune cells, and ductal cells from control and SAP mice. DUSP10 was predominantly expressed in acinar cells and was markedly reduced in acinar cells from SAP mice, supporting an acinar cell-intrinsic role of DUSP10 in pancreatic injury (Fig. S7E). Furthermore, time-course analysis showed that the significant decrease in DUSP10 expression occurred before the marked elevation of serum amylase and pancreatic injury, suggesting that DUSP10 downregulation is an early event during SAP progression rather than merely a consequence of pancreatic damage (Fig. S7F-H). The downregulation of DUSP10 expression suggested that DUSP10 may shield the pancreas from SAP.Fig. 1DUSP10 expression is downregulated after SAP. (A) Heatmap of differential genes. (B) Differential analysis of DUSP10 expression. (C) Serum amylase level and lipase activity in Sham group and SAP group (n = 6 per group). (D) Representative HE staining images of pancreatic tissue of mice in the Sham and SAP groups (n = 6 per group). Scale bar = 100 μm. (E) Immunohistochemical staining of DUSP10 in the pancreas of mice in different groups (n = 6/group). Scale bar = 100 μm. (F) mRNA levels of DUSP10 in vivo and in vitro after SAP. (G) Protein levels of DUSP10 in the pancreas of mice in the Sham and SAP group (representative of three independent experiments). (H) Protein levels of DUSP10 in AR42J cells of NC group and L-Arg group (representative of three independent experiments). (F-H used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant.) DUSP10 expression is downregulated after SAP. (A) Heatmap of differential genes. (B) Differential analysis of DUSP10 expression. (C) Serum amylase level and lipase activity in Sham group and SAP group (n = 6 per group). (D) Representative HE staining images of pancreatic tissue of mice in the Sham and SAP groups (n = 6 per group). Scale bar = 100 μm. (E) Immunohistochemical staining of DUSP10 in the pancreas of mice in different groups (n = 6/group). Scale bar = 100 μm. (F) mRNA levels of DUSP10 in vivo and in vitro after SAP. (G) Protein levels of DUSP10 in the pancreas of mice in the Sham and SAP group (representative of three independent experiments). (H) Protein levels of DUSP10 in AR42J cells of NC group and L-Arg group (representative of three independent experiments). (F-H used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant.) DUSP10 Deficiency exacerbates SAP and SAP-related lung and kidney injury In subsequent experiments, we fused DUSP10−/− and AAV-mediated DUSP10 overexpressing mice to define the function of DUSP10 during SAP. Genomic DNA was isolated from mouse tail tips for genotyping to and confirmation of gene deletions, and further verified by Western blot analysis (Fig. 2A and B). The serotype of AAV is AAV-2/8 with good affinity for the pancreas, was used to specifically overexpress DUSP10 in pancreas cells of mice, and verified by Western blotting (Fig. S2A). Serum amylase and lipase activity levels were higher in DUSP10−/− mice with SAP compared to the sham group (Fig. 2C), and HE staining and pancreas pathology scores also showed more severe pancreatic injury including edema, inflammatory cells infiltration, and necrosis (Fig. 2E and G). In contrast, serum amylase levels and lipase activities were significantly reduced in AAV-DUSP10 mice after SAP, and pancreatic injury was also significantly reduced according to HE staining and pathological scoring of the pancreas (Fig. 2D, F, and H). Furthermore, we generated SAP models in DUSP10−/− and AAV-DUSP10–overexpressing mice using caerulein combined with LPS, and found that DUSP10 similarly attenuated pancreatic injury in this model, consistent with the results observed in the L-arginine–induced SAP model (Fig. S6C-F). These data show that DUSP10 overexpression reduces pancreatic injury, while DUSP10 deletion exacerbates SAP.Fig. 2DUSP10 regulated SAP and SAP-related lung and kidney injury. (A) A mouse tail gene identification kit was used for gene identification, L was DNA Ladder, T1 was water, T2 was WT mice, T3-T6 were DUSP10−/− mice, and T7 was DUSP10 heterozygous (DUSP10 +/-) mice. (B) Protein levels of DUSP10 in the pancreas of WT and DUSP10−/− mice (representative of three independent experiments). (C) Serum amylase levels and lipase viability in WT or DUSP10−/− mice with or without L-Arg treatment. (n = 6 per group). (D) Serum amylase levels and lipase viability in AAV-GFP or AAV-DUSP10 mice with or without L-Arg treatment. (n = 6 per group). (E) Representative HE staining images of pancreatic tissue from mice in the DUSP10−/− experimental group (n = 6 per group). Scale bar = 100 μm. (F) Representative HE staining images of pancreatic tissue from mice in the AAV-DUSP10 experimental group (n = 6 per group). Scale bar = 100 μm. (G) Statistics of pathological injury in the pancreas of mice in the DUSP10−/− experimental group (n = 6 per group). (H) Statistics of pathological injury in the pancreas of mice in the AAV-DUSP10 experimental group (n = 6 per group). (I) Representative HE staining images of lung tissue from mice in the DUSP10−/− experimental group (n = 6 per group). Scale bar = 100 μm. (J) Representative HE staining images of lung tissue from mice in the AAV-DUSP10 experimental group (n = 6 per group). Scale bar = 100 μm. (K) Representative HE staining images of kidney tissue from mice in the DUSP10−/− experimental group (n = 6 per group). Scale bar = 50 μm. (L) Representative HE staining images of kidney tissue from mice in the AAV-DUSP10 experimental group (n = 6 per group). Scale bar = 50 μm. (B used GAPDH as the loading control. All data are expressed as mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns insignificant.) DUSP10 regulated SAP and SAP-related lung and kidney injury. (A) A mouse tail gene identification kit was used for gene identification, L was DNA Ladder, T1 was water, T2 was WT mice, T3-T6 were DUSP10−/− mice, and T7 was DUSP10 heterozygous (DUSP10 +/-) mice. (B) Protein levels of DUSP10 in the pancreas of WT and DUSP10−/− mice (representative of three independent experiments). (C) Serum amylase levels and lipase viability in WT or DUSP10−/− mice with or without L-Arg treatment. (n = 6 per group). (D) Serum amylase levels and lipase viability in AAV-GFP or AAV-DUSP10 mice with or without L-Arg treatment. (n = 6 per group). (E) Representative HE staining images of pancreatic tissue from mice in the DUSP10−/− experimental group (n = 6 per group). Scale bar = 100 μm. (F) Representative HE staining images of pancreatic tissue from mice in the AAV-DUSP10 experimental group (n = 6 per group). Scale bar = 100 μm. (G) Statistics of pathological injury in the pancreas of mice in the DUSP10−/− experimental group (n = 6 per group). (H) Statistics of pathological injury in the pancreas of mice in the AAV-DUSP10 experimental group (n = 6 per group). (I) Representative HE staining images of lung tissue from mice in the DUSP10−/− experimental group (n = 6 per group). Scale bar = 100 μm. (J) Representative HE staining images of lung tissue from mice in the AAV-DUSP10 experimental group (n = 6 per group). Scale bar = 100 μm. (K) Representative HE staining images of kidney tissue from mice in the DUSP10−/− experimental group (n = 6 per group). Scale bar = 50 μm. (L) Representative HE staining images of kidney tissue from mice in the AAV-DUSP10 experimental group (n = 6 per group). Scale bar = 50 μm. (B used GAPDH as the loading control. All data are expressed as mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns insignificant.) To determine whether DUSP10 is also involved in milder pancreatic injury, we further established an LPS-induced mild AP model in WT and DUSP10−/− mice. Compared with WT mice, DUSP10−/− mice showed higher serum amylase levels and more evident pancreatic histopathological injury after mild AP induction. These results suggest that DUSP10 deficiency also aggravates pancreatic injury in a mild AP model, indicating that the protective role of DUSP10 is not limited to the L-Arg-induced SAP model (Fig. S9B-D). Several linked organs may sustain harm when SAP develops. Using an animal model, HE staining was performed on lung and kidney tissues of mice to assess the effect of DUSP10 on organ damage during SAP. After induction of SAP, lung tissue from the DUSP10−/− group exhibited evident edema and inflammatory cells infiltration (Fig. 2I and S3A). Similarly, the kidney sections from the KO group showed renal tubule enlargement, necrosis, brush boundary loss, and remodeling (Fig. 2K and S3C). The lung tissue of AAV-DUSP10 animals had markedly less edema and inflammatory cells infiltration after SAP (Fig. 2J and S3B). Moreover, renal tubule enlargement, necrosis, brush boundary loss, and remodeling were dramatically reduced (Fig. 2L and S3D). Besides, we measured cell counting, total protein and inflammatory factors in BALF, as well as concentrations of blood urea nitrogen (BUN) and creatinine in serum, showing the same trends as in HE pathological injury (Fig. S4A and B, Fig. S7A and B). These results suggest that DUSP10 is a crucial regulator of the SAP-related lung and kidney injury. DUSP10 Deficiency exacerbates inflammatory responses during SAP Next, we measured the levels of serum inflammatory factors in mice. DUSP10 deletion dramatically increased the expression of IL-6, TNF-α, and MCP-1 after SAP induction (Fig. 3A). Similarly, using L-Arg and a rat pancreatic acinar AR42J cell line, we constructed an in vitro model of SAP to better understand the protective effect of DUSP10 on SAP. Three different shRNAs were used to silence DUSP10 in AR42J cells. The knockdown effect of the lentivirus sh-1 sequence was the most pronounced, as shown by our RT-qPCR data (Fig. S1B), verified by Western blotting (Fig. S2B), and was used in subsequent tests. After L-Arg stimulation, we found that pancreatic acinar cells with DUSP10 knockdown had significantly lower survival rates (Fig. S1C-D). The mRNA levels of IL-6, TNF-α, and MCP-1 were also increased (Fig. 3C). Furthermore, IHC staining revealed a dramatic increase in the expression of CD11b, MPO, and Ly6G marked infiltrating inflammatory cells in pancreatic tissue of DUSP10−/− mice after SAP (Fig. 3E and S5A). Furthermore, both in vivo and in vitro, DUSP10 depletion leads to increased levels of phosphorylated p65 after SAP induction (Fig. 3G, S5C and D). These results suggest that DUSP10 deficiency exacerbates the inflammatory responses induced by L-Arg.Fig. 3DUSP10 deficiency exacerbates inflammatory responses during SAP. (A) Statistics for IL-6, TNF-α, and MCP-1 levels in WT or DUSP10−/− mice in the presence or absence of L-Arg (n = 6 per group). (B) Statistics for the levels of IL-6, TNF-α, and MCP-1 in AAV-GFP or AAV-DUSP10 mice under sham or L-Arg challenge (n = 6 per group). (C) The mRNA expression of IL-6, TNF-α, and MCP-1 in AR42J cells of the DUSP10-KD experimental group. (D) The mRNA expression of IL-6, TNF-α, and MCP-1 in AR42J cells of the DUSP10-OE experimental group. (E) Representative immunohistochemical staining of CD11b, MPO, and Ly6G in the pancreas of mice in the DUSP10−/− experimental group (n = 6 per group). Scale bar = 100 μm. (F) Representative immunohistochemical staining of CD11b, MPO, and Ly6G in the pancreas of mice in AAV-GFP or AAV-DUSP10 mice under sham or L-Arg challenge (n = 6 per group). Scale bar = 100 μm. (G) Protein expression levels of p65 and p-p65 in the pancreas of WT or DUSP10−/− mice in the presence or absence of L-Arg and AR42J cells of the DUSP10-KD experimental group (representative of three independent experiments). (H) Protein expression levels of p65 and p-p65 in the pancreas of AAV-GFP or AAV-DUSP10 mice under sham or L-Arg challenge and AR42J cells of the DUSP10-OE experimental group (representative of three independent experiments). (C, D, G and H used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, **p < 0.01, ***p < 0.001, ns not significant.) DUSP10 deficiency exacerbates inflammatory responses during SAP. (A) Statistics for IL-6, TNF-α, and MCP-1 levels in WT or DUSP10−/− mice in the presence or absence of L-Arg (n = 6 per group). (B) Statistics for the levels of IL-6, TNF-α, and MCP-1 in AAV-GFP or AAV-DUSP10 mice under sham or L-Arg challenge (n = 6 per group). (C) The mRNA expression of IL-6, TNF-α, and MCP-1 in AR42J cells of the DUSP10-KD experimental group. (D) The mRNA expression of IL-6, TNF-α, and MCP-1 in AR42J cells of the DUSP10-OE experimental group. (E) Representative immunohistochemical staining of CD11b, MPO, and Ly6G in the pancreas of mice in the DUSP10−/− experimental group (n = 6 per group). Scale bar = 100 μm. (F) Representative immunohistochemical staining of CD11b, MPO, and Ly6G in the pancreas of mice in AAV-GFP or AAV-DUSP10 mice under sham or L-Arg challenge (n = 6 per group). Scale bar = 100 μm. (G) Protein expression levels of p65 and p-p65 in the pancreas of WT or DUSP10−/− mice in the presence or absence of L-Arg and AR42J cells of the DUSP10-KD experimental group (representative of three independent experiments). (H) Protein expression levels of p65 and p-p65 in the pancreas of AAV-GFP or AAV-DUSP10 mice under sham or L-Arg challenge and AR42J cells of the DUSP10-OE experimental group (representative of three independent experiments). (C, D, G and H used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, **p < 0.01, ***p < 0.001, ns not significant.) In order to enhance the elucidation of DUSP10’s protective impact on SAP, adeno-associated virus (AAV) 2/8 systems containing either DUSP10 (AAV-DUSP10) or GFP scramble (AAV-GFP) were injected intraperitoneally into mice to study DUSP10 overexpression in the pancreas. We found that DUSP10 overexpression significantly decreased the expression of IL-6, TNF-α, and MCP-1 after SAP induction (Fig. 3B) and inflammatory cell markers (Fig. 3F and S5B) after SAP induction. In parallel, we found that pancreatic acinar cells treated with DUSP10 overexpression plasmids had greater levels of DUSP10 protein expression (Fig. S2C), significantly higher survival rates after L-Arg stimulation (Fig. S1E-F) and reduced expression of IL-6, TNF-α, and MCP-1 mRNA (Fig. 3D). Furthermore, after SAP induction, DUSP10 overexpression reduced the phosphorylation of p65 both in vivo and in vitro (Fig. 3H, S5E and F). Collectively, these suggest that DUSP10 overexpression ameliorates the inflammatory responses during SAP. DUSP10 Deficiency exacerbates oxidative stress during SAP To better elucidate the protective effect of DUSP10 on SAP, we evaluated markers of oxidative stress in pancreatic tissue. These adverse factors promote the release of pro-inflammatory cytokines. Compared to the WT group after SAP, GSH and SOD levels were lower in the DUSP10−/− mice, the production of the oxidation product H2O2 and the lipid peroxidation marker MDA was higher (Fig. 4A). Similarly, we found that pancreatic acinar cells with DUSP10 knockdown produced more MDA and less GSH and SOD after L-Arg stimulation (Fig. 4C), as well as higher levels of cellular ROS (Fig. 4E). In addition, DUSP10−/− mice had significantly increased expression of the peroxidation product 4-HNE (Fig. 4G and S5G). The expression of antioxidant proteins, such as HO-1 and NQO-1 was reduced in DUSP10−/− mice and AR42J cells with the DUSP10-KD (Fig. S5I and J).Fig. 4DUSP10 deficiency exacerbates oxidative stress during SAP. (A) Statistics for the levels of GSH, H2O2, SOD, and MDA in the pancreas of mice in the DUSP10−/− experimental group (n = 6 per group). (B) Statistics for the levels of GSH, H2O2, SOD, and MDA in the pancreas of mice in the AAV-DUSP10 experimental group (n = 6 per group). (C) The levels of GSH, SOD, and MDA in AR42J cells in the DUSP10-KD experimental group. (D) The levels of GSH, SOD, and MDA in AR42J cells in the DUSP10-OE experimental group. (E) Representative images showing ROS in the AR42J cells of the DUSP10-KD experimental group. Scale bar = 100 μm. (F) Representative images showing ROS in the AR42J cells of the DUSP10-OE experimental group. Scale bar = 100 μm. (G) Representative immunohistochemical staining of 4-HNE in the pancreas of mice in the DUSP10−/− experimental group (n = 6 per group). Scale bar = 100 μm. (H) Representative immunohistochemical staining of 4-HNE in the pancreas of mice in the AAV-DUSP10 experimental group (n = 6 per group). Scale bar = 100 μm. (All data are expressed as the mean ± SD; * p < 0.05, **p < 0.01, ***p < 0.001, ns not significant.) DUSP10 deficiency exacerbates oxidative stress during SAP. (A) Statistics for the levels of GSH, H2O2, SOD, and MDA in the pancreas of mice in the DUSP10−/− experimental group (n = 6 per group). (B) Statistics for the levels of GSH, H2O2, SOD, and MDA in the pancreas of mice in the AAV-DUSP10 experimental group (n = 6 per group). (C) The levels of GSH, SOD, and MDA in AR42J cells in the DUSP10-KD experimental group. (D) The levels of GSH, SOD, and MDA in AR42J cells in the DUSP10-OE experimental group. (E) Representative images showing ROS in the AR42J cells of the DUSP10-KD experimental group. Scale bar = 100 μm. (F) Representative images showing ROS in the AR42J cells of the DUSP10-OE experimental group. Scale bar = 100 μm. (G) Representative immunohistochemical staining of 4-HNE in the pancreas of mice in the DUSP10−/− experimental group (n = 6 per group). Scale bar = 100 μm. (H) Representative immunohistochemical staining of 4-HNE in the pancreas of mice in the AAV-DUSP10 experimental group (n = 6 per group). Scale bar = 100 μm. (All data are expressed as the mean ± SD; * p < 0.05, **p < 0.01, ***p < 0.001, ns not significant.) Opposite, we found that pancreatic DUSP10 overexpression significantly increased the expression of GSH, SOD and decreased the levels of H2O2, MDA (Fig. 4B). Similar patterns for GSH, MDA, and SOD levels were found in AR42J cells with DUSP10 overexpression and decreased cellular ROS levels (Fig. 4D and F). In addition, the activity of the peroxidation by-product 4-HNE was dramatically reduced in AAV-DUSP10 mice (Fig. 4H and S5H). Antioxidant proteins (HO-1 and NQO-1) were more highly expressed in in vitro and in vivo DUSP10-OE experiments (Fig. S5K and L). These results suggested that DUSP10 regulated the oxidative stress level in SAP. DUSP10 Deficiency exacerbates pyroptosis during SAP Pyroptosis is a form of inflammatory cell death driven by the gasdermin (GSDM) protein family and is gradually recognized for its significant contribution to the development of SAP. We examined representative proteins of NOD-like receptor protein 3 (NLRP3) inflammasome-mediated pyroptosis (NLRP3, ASC, Caspase-1, GSDMD-N/GSDMD, and IL-1β) by Western blotting, and found high expression of these products in DUSP10−/− mice and AR42J cells when DUSP10 was knocked down (Fig. 5A, C and E). Opposite, pyroptosis marker proteins were reduced in both in vitro and in vivo DUSP10-OE experiments (Fig. 5B, D and H). During pyroptosis, caspase-1 is activated and processes inactive precursors of IL-1β and IL-18, generating their active forms. These cytokines are pivotal in recruiting inflammatory cells to the extracellular space, thereby amplifying the inflammatory response, and contributing substantially to the inflammatory signaling cascade. Concurrently, pores form on the cell membrane, leading to the release of cytoplasmic contents, including lactate dehydrogenase (LDH) and additional inflammatory cytokines. This pore formation is a hallmark of pyroptotic cell death, further exacerbating the inflammatory response. We measured levels of pyroptosis-related factors IL-1β and IL-18 in both in vivo experiments with DUSP10−/− and overexpression (Fig. S3E and F). Additionally, we evaluated the transcription levels of IL-1β and IL-18 (Fig. 5F and I), as well as LDH release (Fig. 5G and J), in in vitro experiments with DUSP10 knockdown and overexpression. These results were consistent with the trends observed in pyroptosis marker proteins, and suggested that DUSP10 deficiency exacerbated pyroptosis during SAP.Fig. 5DUSP10 regulated pyroptosis during SAP. (A) Protein expression levels of NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in the pancreas of WT or DUSP10−/− mice in the presence or absence of L-Arg and AR42J cells of the DUSP10-KD experimental group (representative of three independent experiments). (B) Protein expression levels of NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in the pancreas of WT or AAV-DUSP10 mice in the presence or absence of L-Arg and AR42J cells of the DUSP10-OE experimental group (representative of three independent experiments). (C) Statistical analysis of NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in the pancreas of WT or DUSP10−/− mice in the presence or absence of L-Arg. (D) Statistical analysis of NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in the pancreas of AAV-GFP or AAV-DUSP10 mice under sham or L-Arg challenge. (E) Statistical analysis of NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in AR42J cells of the DUSP10-KD experimental group. (F) The mRNA expression of IL-1β and IL-18 in AR42J cells of the DUSP10-KD experimental group. (G) LDH release level of AR42J cells in the DUSP10-KD experimental group. (H) Statistical analysis of NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in AR42J cells of the DUSP10-OE experimental group. (I) The mRNA expression of IL-1β and IL-18 in AR42J cells of the DUSP10-OE experimental group. (J) LDH release level of AR42J cells in the DUSP10- OE experimental group. (C, D, E, F, H and I used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant.) DUSP10 regulated pyroptosis during SAP. (A) Protein expression levels of NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in the pancreas of WT or DUSP10−/− mice in the presence or absence of L-Arg and AR42J cells of the DUSP10-KD experimental group (representative of three independent experiments). (B) Protein expression levels of NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in the pancreas of WT or AAV-DUSP10 mice in the presence or absence of L-Arg and AR42J cells of the DUSP10-OE experimental group (representative of three independent experiments). (C) Statistical analysis of NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in the pancreas of WT or DUSP10−/− mice in the presence or absence of L-Arg. (D) Statistical analysis of NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in the pancreas of AAV-GFP or AAV-DUSP10 mice under sham or L-Arg challenge. (E) Statistical analysis of NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in AR42J cells of the DUSP10-KD experimental group. (F) The mRNA expression of IL-1β and IL-18 in AR42J cells of the DUSP10-KD experimental group. (G) LDH release level of AR42J cells in the DUSP10-KD experimental group. (H) Statistical analysis of NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in AR42J cells of the DUSP10-OE experimental group. (I) The mRNA expression of IL-1β and IL-18 in AR42J cells of the DUSP10-OE experimental group. (J) LDH release level of AR42J cells in the DUSP10- OE experimental group. (C, D, E, F, H and I used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant.) Inhibition of pyroptosis protected against DUSP10 deficiency in aggravating SAP To further verify whether DUSP10 deficiency aggravated SAP through regulating pyroptosis, We used a potent pyroptosis inhibitor (DSF) to directly covalently modify GSDMD or indirectly inhibit GSDMD cleavage by inactivating the NLRP3 inflammasome in DUSP10−/− mice. Effectiveness of DSF as inhibitors in SAP verified by Western blotting in in vitro experiments (Fig. S2D). DUSP10−/− mice pre-treated with DSF had reduced serum amylase levels and lipase activity than mice treated with L-Arg alone (Fig. 6A). Their pancreatic tissues showed less edema, inflammation, and necrosis (Fig. 6B and C). In addition, we found that DSF therapy reduced the serum expression of IL-6, TNF-α, MCP-1, the number of CD11b-, MPO- and Ly6G-positive inflammatory cells in pancreas, and the levels of p-p65 after L-Arg-induced SAP production (Fig. 6D, F and Fig. S2F).Fig. 6Inhibition of pyroptosis protected against DUSP10 deficiency in aggravating SAP. (A) Serum amylase levels and lipase viability in WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (B) Representative HE staining images of the pancreas in WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). Scale bar=100 μm. (C) Statistics of pathological damage in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (D) Statistics of levels of IL-6, TNF-α, and MCP-1 in WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (E) Statistics for IL-1β and IL-18 levels in WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (F) Representative immunohistochemical staining of CD11b, MPO, and Ly6G in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). Scale bar=100 μm. (G) Protein expression levels and statistical analysis of p65 and p-p65 in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (representative of three independent experiments). (G used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant.) Inhibition of pyroptosis protected against DUSP10 deficiency in aggravating SAP. (A) Serum amylase levels and lipase viability in WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (B) Representative HE staining images of the pancreas in WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). Scale bar=100 μm. (C) Statistics of pathological damage in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (D) Statistics of levels of IL-6, TNF-α, and MCP-1 in WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (E) Statistics for IL-1β and IL-18 levels in WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (F) Representative immunohistochemical staining of CD11b, MPO, and Ly6G in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). Scale bar=100 μm. (G) Protein expression levels and statistical analysis of p65 and p-p65 in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (representative of three independent experiments). (G used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant.) DSF treatment also markedly diminished the levels of H2O2, MDA, and the peroxidation product 4-HNE, while also suppressing pyroptosis marker proteins and reducing serum levels of pyroptosis-related factors IL-1β and IL-18. In contrast, compared to the DUSP10−/−+SAP group, the treatment bolstered the expression of antioxidant molecules (GSH and SOD) as well as antioxidant proteins (HO-1 and NQO-1), in pancreatic tissue (Figs. 6E and 7A, B and C, and D). Similarly, following DSF treatment, the severity of SAP-related lung and kidney injuries was decreased, with reduced HE staining (Fig. 7E, F, G, and H), decreased cell counts, total protein and inflammatory factors in BALF, and lower serum concentrations of BUN and creatinine (Fig. S4C, Fig. S7C). Altogether, these results suggest that DUSP10 knockout exacerbates SAP by aggravating pyroptosis.Fig. 7Inhibition of pyroptosis protected against DUSP10 deficiency in aggravating oxidative stress and SAP-related lung and kidney injury. (A) Statistics for the levels of oxidative stress (GSH, H2O2, SOD, and MDA) in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (B) Representative immunohistochemical staining of 4-HNE in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). Scale bar = 100 μm. (C) Statistical analysis of 4-HNE in WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (D) Protein expression levels and statistical analysis of NQO-1, HO-1, NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (representative of three independent experiments). (E) Representative HE staining images of lung tissue from WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). Scale bar = 100 μm. (F) Representative HE staining images of kidney tissue from WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). Scale bar = 50 μm. (G) Statistics of pathological damage in the lung of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (H) Statistics of pathological damage in the kidney of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (D used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant.) Inhibition of pyroptosis protected against DUSP10 deficiency in aggravating oxidative stress and SAP-related lung and kidney injury. (A) Statistics for the levels of oxidative stress (GSH, H2O2, SOD, and MDA) in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (B) Representative immunohistochemical staining of 4-HNE in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). Scale bar = 100 μm. (C) Statistical analysis of 4-HNE in WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (D) Protein expression levels and statistical analysis of NQO-1, HO-1, NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (representative of three independent experiments). (E) Representative HE staining images of lung tissue from WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). Scale bar = 100 μm. (F) Representative HE staining images of kidney tissue from WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). Scale bar = 50 μm. (G) Statistics of pathological damage in the lung of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (H) Statistics of pathological damage in the kidney of WT and DUSP10−/− mice pre-treated with DMSO or DSF after L-Arg treatment (n = 6 per group). (D used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant.) DUSP10 Deficiency exacerbated pyroptosis via enhanced TAK1 phosphorylation during SAP DUSP10 is also known as MKP5 [24]. The mitogen-activated protein kinase (MAPK) signaling pathway is among the pathways implicated in controlling the cell survival and inflammatory response following SAP [39, 40]. Thus, we postulated that DUSP10 would protect the pancreas from L-Arg-induced SAP damage in a MAPK-dependent manner. We investigated whether there was a direct link between DUSP10 and TAK1, given that DUSP10 inhibits the activation of p38 and c-Jun N-terminal kinase (JNK), suggesting that DUSP10 may affect TAK1, an upstream regulator of both p38 and JNK [35, 36, 41]. And confirmed that DUSP10 and TAK1 could form a complex through immunofluorescence and coimmunoprecipitation (Fig. 8A and B, Fig. S8E). To further determine whether TAK1 is directly dephosphorylated by DUSP10, we performed an in vitro dephosphorylation assay. Phosphorylated TAK1 was immunoprecipitated from L-Arg-treated AR42J cells and incubated with DUSP10 proteins extracted from cells transfected with wild-type DUSP10 or a catalytically inactive DUSP10 mutant. Wild-type DUSP10 markedly reduced p-TAK1 levels without altering total TAK1, whereas the inactive mutant did not show this effect, indicating that DUSP10 dephosphorylates TAK1 in a phosphatase activity-dependent manner (Fig. S8A). We then tested whether DUSP10 controls TAK1/JNK/p38 pathway during SAP. In DUSP10−/− mouse pancreatic tissue after SAP, phosphorylated TAK1, JNK, and p38 protein levels increased compared to WT mice (Fig. 8C), indicating that the MAPK pathway was activated. In contrast, TAK1, JNK, and p38 phosphorylation were decreased in AAV-DUSP10 mice (Fig. 8E). We observed a similar trend in AR42J cells that had undergone SAP injury, which is consistent with our in vivo observations (Fig. 8D and F).Fig. 8TAK1 and its downstream signaling pathways are involved in DUSP10-regulated SAP. (A) A immunofluorescence assay was performed in AR42J cells transfected with Flag-DUSP10 to examine the interaction between TAK1 and DUSP10. (B) A CO-IP assay was performed in AR42J cells transfected with Flag-DUSP10 to examine the interaction between TAK1 and DUSP10. (C) Protein expression levels and statistical analysis of P-TAK1, TAK1, p-JNK, JNK, p-p38, and p38 in the pancreas of WT or DUSP10−/− mice in the presence or absence of L-Arg (representative of three independent experiments). (D) Protein expression levels and statistical analysis of p-TAK1, TAK1, p-JNK, JNK, p-p38, and p38 in AR42J cells of the DUSP10-KD experimental group (representative of three independent experiments). (E) Protein expression levels and statistical analysis of p-TAK1, TAK1, p-JNK, JNK, p-p38, and p38 in AAV-GFP and AAV-DUSP10 mice in the presence or absence of L-Arg (representative of three independent experiments). (F) Protein expression levels and statistical analysis of p-TAK1, TAK1, p-JNK, JNK, p-p38, and p38 in AR42J cells of the DUSP10-OE experimental group (representative of three independent experiments). (C, D, E, and F used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant.) TAK1 and its downstream signaling pathways are involved in DUSP10-regulated SAP. (A) A immunofluorescence assay was performed in AR42J cells transfected with Flag-DUSP10 to examine the interaction between TAK1 and DUSP10. (B) A CO-IP assay was performed in AR42J cells transfected with Flag-DUSP10 to examine the interaction between TAK1 and DUSP10. (C) Protein expression levels and statistical analysis of P-TAK1, TAK1, p-JNK, JNK, p-p38, and p38 in the pancreas of WT or DUSP10−/− mice in the presence or absence of L-Arg (representative of three independent experiments). (D) Protein expression levels and statistical analysis of p-TAK1, TAK1, p-JNK, JNK, p-p38, and p38 in AR42J cells of the DUSP10-KD experimental group (representative of three independent experiments). (E) Protein expression levels and statistical analysis of p-TAK1, TAK1, p-JNK, JNK, p-p38, and p38 in AAV-GFP and AAV-DUSP10 mice in the presence or absence of L-Arg (representative of three independent experiments). (F) Protein expression levels and statistical analysis of p-TAK1, TAK1, p-JNK, JNK, p-p38, and p38 in AR42J cells of the DUSP10-OE experimental group (representative of three independent experiments). (C, D, E, and F used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant.) To further identify the predominant downstream pathway involved in DUSP10-mediated regulation of SAP, we treated L-Arg-stimulated AR42J cells with specific inhibitors of JNK or p38. JNK inhibition more prominently reversed the SAP-related cellular injury and downstream signaling alterations associated with DUSP10 dysregulation, whereas p38 inhibition showed a relatively weaker effect. These results suggest that DUSP10 regulates SAP primarily through the TAK1/JNK signaling branch, with p38 acting as an additional contributing pathway (Fig. S8B and C). To ascertain TAK1’s involvement in DUSP10’s protective role, we employed a specific TAK1 inhibitor (5Z-7-ox) to block the activity of TAK1 to inhibit the activation of downstream JNK/p38 signaling. Effectiveness of 5Z-7-ox as inhibitors in SAP verified by Western blotting in in vitro experiments (Fig. S2E). 5Z-7-ox administration significantly decreased the severity of SAP, which was exhibited with the reduced amylase and lipase activity (Fig. 9A), attenuated pancreatic injury (Fig. 9B and C), decreased level of serum inflammatory factors (Fig. 9D), diminished infiltration of inflammatory cells (Fig. 9F and Fig. S2G), and less phosphorylation of p65 (Fig. 9G). Furthermore, 5Z-7-ox treatment significantly downregulated the expressions of H2O2, MDA, and 4-HNE in contrast to increasing the expression of GSH, SOD, HO-1 and NQO-1 in the pancreatic tissue of DUSP10−/−+SAP group (Fig. 10A, B, C and D). The inhibition of TAK1 significantly alleviated the pyroptosis after SAP, as shown by the decreased expression of pyroptosis marker proteins and the serum concentrations of IL-1β and IL-18 in KO mice compared with corresponding control groups (Figs. 9E and 10D). Meanwhile, 5Z-7-ox treatment can also protect against DUSP10 deficiency in activating TAK1/JNK/p38 pathway and exacerbating SAP-related lung and kidney injury (Fig. 10E, F, G and Fig. S1G, H and Fig. S4D and Fig. S7D). These observations suggest that DUSP10−/− exacerbated pancreatic injury and pyroptosis via the dephosphorylation of TAK1 during SAP.Fig. 9DUSP10 mitigated inflammatory responses during SAP by suppressing TAK1. (A) Serum amylase levels and lipase viability in WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). (B) Representative HE staining images of the pancreas in WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). Scale bar=100 μm. (C) Statistics of pathological damage in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). (D) Statistics of levels of IL-6, TNF-α, and MCP-1 in WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). (E) Statistics for IL-1β and IL-18 levels in WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). (F) Representative immunohistochemical staining of CD11b, MPO, and Ly6G in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). Scale bar=100 μm. (G) Protein expression levels and statistical analysis of p65 and p-p65 in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (representative of three independent experiments). (G used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant.)Fig. 10DUSP10 deficiency exacerbated pyroptosis via enhanced TAK1 phosphorylation during SAP. (A) Statistics for the levels of oxidative stress (GSH, H2O2, SOD, and MDA) in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). (B) Representative immunohistochemical staining of 4-HNE in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). Scale bar = 100 μm. (C) Statistical analysis of 4-HNE in WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). (D) Protein expression levels and statistical analysis of NQO-1, HO-1, NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (representative of three independent experiments). (E) Protein expression levels and statistical analysis of p-TAK1, TAK1, p-JNK, JNK, p-p38, and p38 in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (representative of three independent experiments). (F) Representative HE staining images of lung tissue from WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). Scale bar = 100 μm. (G) Representative HE staining images of kidney tissue from WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). Scale bar = 50 μm. (D and E used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant.) DUSP10 mitigated inflammatory responses during SAP by suppressing TAK1. (A) Serum amylase levels and lipase viability in WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). (B) Representative HE staining images of the pancreas in WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). Scale bar=100 μm. (C) Statistics of pathological damage in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). (D) Statistics of levels of IL-6, TNF-α, and MCP-1 in WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). (E) Statistics for IL-1β and IL-18 levels in WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). (F) Representative immunohistochemical staining of CD11b, MPO, and Ly6G in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). Scale bar=100 μm. (G) Protein expression levels and statistical analysis of p65 and p-p65 in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (representative of three independent experiments). (G used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant.) DUSP10 deficiency exacerbated pyroptosis via enhanced TAK1 phosphorylation during SAP. (A) Statistics for the levels of oxidative stress (GSH, H2O2, SOD, and MDA) in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). (B) Representative immunohistochemical staining of 4-HNE in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). Scale bar = 100 μm. (C) Statistical analysis of 4-HNE in WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). (D) Protein expression levels and statistical analysis of NQO-1, HO-1, NLRP3, ASC, Caspase-1, GSDMD, GSDMD-N, IL-1β in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (representative of three independent experiments). (E) Protein expression levels and statistical analysis of p-TAK1, TAK1, p-JNK, JNK, p-p38, and p38 in the pancreas of WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (representative of three independent experiments). (F) Representative HE staining images of lung tissue from WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). Scale bar = 100 μm. (G) Representative HE staining images of kidney tissue from WT and DUSP10−/− mice pre-treated with DMSO or 5Z-7-ox after L-Arg treatment (n = 6 per group). Scale bar = 50 μm. (D and E used GAPDH as the loading control. All data are expressed as the mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, ns not significant.) To explore the potential upstream mechanism responsible for DUSP10 downregulation, we predicted transcription factors targeting the DUSP10 promoter using JASPAR. Cross-species comparison between human and mouse prediction results identified one conserved candidate, ZNF436/Zfp46. Correlation analysis showed a positive association between ZNF436 and DUSP10 expression. Moreover, dual-luciferase reporter assays demonstrated that ZNF436 increased the activity of the wild-type DUSP10 promoter, whereas mutation of the predicted ZNF436-binding site markedly attenuated this effect. These findings suggest that ZNF436/Zfp46 may act as an upstream transcriptional activator of DUSP10 (Fig. S9E-G). Discussion AP as a common emergency abdominal condition, presents clinically with acute, persistent upper abdominal pain and subsequent complications. The severity of the condition can range from mild to severe, depending not only on the degree of local injury in and around the pancreas but, more importantly, on the presence or absence of systemic injury dominated by distal organ dysfunction [41]. Approximately 20% of AP patients present with a more severe form of the disease that is associated with higher mortality, usually caused by persistent SIRS and organ dysfunction due to systemic inflammatory responses [42, 43]. Cellular damage such as oxidative stress, pyroptosis, endoplasmic reticulum stress, and necroptosis are also involved in the development of AP [15, 44–46]. DUSP10, an upstream molecule in the MAPK pathway, acts as a negative regulatory role in several inflammatory diseases [24]. Our investigation found that DUSP10 expression was downregulated in the sera of SAP patients compared to healthy subjects by searching online open-source, public databases, which is consistent with its molecular mechanism of inhibiting JNK and p38 phosphorylation. We then treated C57BL6 mice and AR42J cells with L-Arg to create in vivo and in vitro models of SAP, and found a significant increase of serum amylase levels and lipase activity in mice after L-Arg stimulation, accompanied by pathological changes in the pancreas, such as increased edema, more necrotic cells, massive inflammatory cells infiltration, and an increase in hemorrhage, demonstrating successful modeling of SAP. We established a significant reduction in DUSP10 expression after pancreatic SAP in mice using AAV. Our in vivo findings were consistent with our in vitro experimental results and theoretical hypothesis. Inflammatory response is pivotal in SAP. The release of large amounts of chemokines, cytokines, and adhesion factors mediating the aggregated activation of neutrophils and macrophages following pancreatic acinar cell injury promotes the further release of systemic cytokines and inflammatory mediators, leading to severe pancreatic necrosis and peripheral organ damage, and amplifies the inflammatory cascade response, promoting SIRS and MODS [47, 48]. As the first immune cells recruited to the pancreas and lung, activated neutrophils can also produce an extracellular adhesion network containing granulins, DNA, and histones to block pancreatic ducts, promote trypsinogen activation in pancreatic acinar cells and further exacerbate pro-inflammatory signaling, including via pressure-signaling sensors [49, 50]. Given the central role of the development of the inflammation in AP and the partially reported role of DUSP10 in inflammatory response, we propose that modulation of AP development may be achieved through inhibition and activation of DUSP10 molecular targets. Our study showed that systemic DUSP10 knockdown in mice resulted in significantly increased of IL-6, TNF-α, and MCP-1, as well as significantly increased expression of the inflammatory cell markers CD11b, MPO, and Ly6G by immunohistochemistry. Furthermore, activation of the NF-κB pathway, as the key inflammatory regulatory pathway, was more pronounced in the pancreatic tissue of DUSP10−/− mice than in WT mice, as evidenced by increased phosphorylation of its signature protein P65 [51]. In contrast, inflammation was lower in the pancreas of AAV-DUSP10 mice compared to L-Arg-treated AAV-GFP mice. Similar to the in vivo experiments, we obtained the same results for the above inflammatory markers in rat pancreatic acinar cells, which were engineered for DUSP10 expression by plasmid and knockdown lentivirus transfection and treated with L-Arg. We conclude that DUSP10 can significantly reduce the inflammatory response in AP. The equilibrium between oxidative stress and antioxidant defense is crucial for pancreatic acinar cell viability [52]. In early AP, an imbalance results in oxidative stress and is considered the initiating factor for numerous pathological mechanisms [53, 54]. In AP, large amounts of oxygen radicals produced by pancreatic tissues can react with unsaturated fatty acids on biological membranes forming cytotoxic lipid peroxides like MDA. These compounds exacerbate membrane damage, and disrupting normal cellular functions [55]. The high expression of ROS can also further activate inflammatory pathways and amplify the inflammatory cascade response [56]. In contrast, by scavenging oxygen free radicals, the critical antioxidant enzymes SOD and GSH can reduce the damage caused by peroxides such as ROS and H2O2 in cells [57, 58]. Consequently, researchers frequently assess oxidative stress levels by measuring H₂O₂ and MDA concentrations alongside SOD and GSH activity. DUSP10 has been shown to attenuate LPS-induced vascular damage by inhibiting ROS [59]. In addition, DUSP10 can also attenuate palmitic acid (PA)-induced pancreatic β-cell dysfunction by curbing oxidative stress [30]. This is in line with our findings. In the present study, we showed that inhibition of DUSP10 led to elevated ROS, H₂O₂, and MDA levels while diminishing SOD and GSH activity. Conversely, overexpressing DUSP10 had the opposite effect—reducing oxidative markers and boosting antioxidant enzyme activity. These results strongly suggest DUSP10 mitigates oxidative stress following pancreatic SAP injury. Pyroptosis, a recently discovered form of regulated cell death whose classical pathway manifests as NLRP3-regulated, caspase-1-mediated, GSDMD-mediated cell lysis as an effector protein, is also an important factor in the development of AP [60–62]. In mice of NLRP3 or GSDMD knockout, damage and necrosis of pancreatic acinar cells were reduced [13]. In contrast, inhibition of pyroptosis attenuates pancreatic and peripheral organ damage in AP [63]. In the present study, we found that pyroptosis significantly increased after L-Arg stimulation was administered against mouse and AR42J cells. In contrast, inhibition and overexpression of DUSP10 promoted and attenuated pyroptosis after pancreatic AP, respectively, as evidenced by a corresponding increase and decrease in the expression of pyroptosis classical pathway marker proteins (NLRP3, ASC, caspase1, GSDMD-N/GSDMD, and IL-1β) and the serum levels of pyroptosis-related factors IL-1β and IL-18. Then, we performed additional rescue experiments to investigate the relationship between DUSP10 and pyroptosis using a classical pyroptosis inhibitor (DSF) to pre-treat DUSP KO mice and significantly alleviated the severity of SAP, confirming that DUSP10 is an upstream regulator of pyroptosis, consistent with published studies [64]. The MAPK family, consisting of ERK, JNK, and p38, plays a critical role in key biological functions, including cell proliferation, oxidative stress, inflammatory responses, and apoptosis in AP. Targeting MAPK is a potential strategy to alleviate SAP [16–20, 28, 32]. In the present study, we found that JNK/p38 phosphorylation was markedly elevated in both DUSP10−/− mice and AR42J cells with DUSP10 knockdown, but significantly reduced in DUSP10 overexpression models. Further investigation into TAK1, a shared upstream regulator of JNK and p38, and showed that DUSP10 deletion or knockdown significantly increased TAK1 phosphorylation, whereas DUSP10 overexpression inhibited it. In addition, direct physical binding of DUSP10 to TAK1 was successfully demonstrated by immunofluorescence and immunoprecipitation assays. The in vitro dephosphorylation assay further supports TAK1 as a direct substrate of DUSP10 in the context of SAP. Inhibition of TAK1 activity by a specific inhibitor of TAK1 (5Z-7-oxozeaenol) was also used to reverse DUSP10 knockdown-induced pancreatic injury and pyroptosis in mice. These observations suggest that DUSP10 can inhibit the phosphorylation of TAK1 and TAK1-regulated pyroptosis to attenuate SAP. This study has several limitations. First, the functional experiments were mainly based on global DUSP10 knockout mice and AAV-mediated DUSP10 overexpression rather than pancreatic acinar cell-specific conditional models; therefore, systemic effects cannot be fully excluded. Second, because DUSP10 is generally characterized as an intracellular dual-specificity phosphatase, our study focused on its intracellular regulation of TAK1/JNK/p38 signaling and pyroptosis. The potential existence and biological significance of extracellular DUSP10 during SAP remain to be investigated. Finally, larger independent clinical cohorts are needed to validate the association between DUSP10 expression and SAP severity. In summary, our study demonstrates that DUSP10 is a novel target to protect the pancreas from SAP damage and reveals the important role to attenuate pancreatic injury and pyroptosis via the dephosphorylation of TAK1 during SAP. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 (DOCX 9.45 MB) Supplementary Material 1 (DOCX 9.45 MB)